Aardvark Therapeutics (AARD) Misses Q4 EPS by 81c

Aardvark Therapeutics (NASDAQ: AARD) reported Q4 EPS of ($0.81).

For earnings history and earnings-related data on Aardvark Therapeutics (AARD) click here.

You May Also Be Interested In

• Important Notice to Long-Term Shareholders Aardvark Therapeutics, Inc. (NASDAQ: AARD); Flotek Industries, Inc. (NYSE: FTK); GoDaddy Inc. (NYSE: GDDY); and Hub Group, Inc. (NASDAQ: HUBG); Grabar Law Of
• Corvex hires Cushman & Wakefield director to lead data center sourcing
• Benchmark Reiterates Buy Rating on Malibu Boats (MBUU) on Significant Earnings Upside